QUATERNARY AMMONIUM GROUPS ARE NOT CRUCIAL FOR THE ALLOSTERIC EFFECT OF GALLAMINE ON THE HUMAN M2 MUSCARINIC RECEPTOR

被引：0
|
作者：
VANHIJFTE, L [1 ]
ZERR, V [1 ]
HIBERT, M [1 ]
VANGIERSBERGEN, PLM [1 ]
机构：
[1] MARION MERRELL DOW RES INST,F-67080 STRASBOURG,FRANCE
来源：
MEDICINAL CHEMISTRY RESEARCH | 1995年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
An analog of gallamine was synthesized which might covalently bind to the allosteric site on the m(2) muscarinic receptor. During the course of the pharmacological evaluation of this new alkylating agent it was discovered that also non-quaternary analogs of gallamine cause an allosteric modulation of H-3-N-methylscopolamine (H-3-NMS) binding to the muscarinic m2 receptors expressed in A9L cells.
引用
收藏
页码：449 / 454
页数：6
相关论文
共 50 条
  • [21] Structure/activity relationships of M2 muscarinic allosteric modulators
    Mohr, K
    Tränkle, C
    Holzgrabe, U
    RECEPTORS & CHANNELS, 2003, 9 (04): : 229 - 240
  • [22] A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor
    Steinfeld, Tod
    Mammen, Mathai
    Smith, Jacqueline A. M.
    Wilson, Richard D.
    Jasper, Jeffrey R.
    MOLECULAR PHARMACOLOGY, 2007, 72 (02) : 291 - 302
  • [23] Enhanced Conformational Sampling of M2 Muscarinic Acetylcholine Receptor for Designing Selective Allosteric Drugs
    Miao, Yinglong
    McCammon, J. Andrew
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 26A - 26A
  • [24] Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators
    May, LT
    Lin, Y
    Sexton, PM
    Christopoulos, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (01): : 382 - 390
  • [25] A FRET-based M2 muscarinic receptor sensor to study the mechanisms of allosteric modulation
    Maier-Peuschel, M.
    Nikolaev, V. O.
    Hoffmann, C.
    Lohse, M. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 15 - 15
  • [26] Mapping of Allosteric Druggable Sites in Activation-Associated Conformers of the M2 Muscarinic Receptor
    Miao, Yinglong
    Nichols, Sara E.
    McCammon, J. Andrew
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 83 (02) : 237 - 246
  • [27] Orthosteric and allosteric ligands differentially influence the conformational change of the M2 muscarinic acetylcholine receptor
    Baetz, J.
    Kloeckner, J.
    Ziegler, N.
    Froelich, N.
    Zabel, U.
    Holzgrabe, U.
    Mohr, K.
    Lohse, M. J.
    Hoffmann, C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 9 - 9
  • [28] Using molecular dynamics studies of the M2 Muscarinic receptor to enchance design of allosteric modulators
    Goldfeld, Dahlia
    McCammon, J. Andrew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [29] Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups
    Jin, Qi
    Davis, Roderick S.
    Bullion, Ann M.
    Jin, Jian
    Wang, Yonghui
    Widdowson, Katherine L.
    Palovich, Michael R.
    Foley, James J.
    Schmidt, Dulcie B.
    Buckley, Peter T.
    Webb, Edward F.
    Salmon, Michael
    Belmonte, Kristen E.
    Sarau, Henry M.
    Busch-Petersen, Jakob
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7087 - 7091
  • [30] The allosteric core region of the M2 muscarinic acetylcholine receptor differentially regulates allosteric, orthosteric and dualsteric ligand activity
    Chirinda, B.
    Bock, A.
    Mohr, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S3 - S3
12345